Servo-c from Getinge AB - compact ICU ventilator with transport flexibility

Reviewed: ad hoc news Bestseller & Flagship desk. Edited and checked on 2026-06-23, 00:38. Details in the imprint.

The Servo-c from Getinge AB sits on its rolling stand in a bright ICU room, its 12-inch screen glowing softly while a therapist’s gloved finger taps through ventilation modes between beeps from the monitors.

Where Servo-c fits in care

Servo-c is Getinge’s compact ventilator designed for adult and pediatric patients in intensive care, intermediate care, and emergency departments, with optional neonatal functionality. Official Servo-c product page Its design targets hospitals that need full-featured ventilation in units where space and budgets are tight.

Product manager Henrik Nilsson describes Servo-c as “a workhorse for everyday ventilation,” focusing on core modes and monitoring while borrowing interface concepts from the higher-end Servo-u family. Nurses see the same clean layout with waveforms and loops, only on a more compact footprint.

Key modes and monitoring tools

Servo-c offers volume-controlled and pressure-controlled ventilation, pressure support, SIMV, and non-invasive ventilation, aiming to cover common ICU and high-dependency scenarios. Getinge ventilation overview The system can display pressure, flow, and volume curves as well as loops for quick bedside assessment of lung mechanics.

Clinicians can follow trends for parameters such as tidal volume, respiratory rate, and peak pressure, helping teams like anesthesiologist Dr. Maria Svensson decide whether a patient is ready for weaning. Touch gestures make it simple to zoom in on a curve or adjust alarms with just a few taps.

Design, ergonomics and mobility

The ventilator offers a 12.1-inch color touchscreen mounted on a compact mobile cart, with hooks for circuits and a tidy cable layout to reduce bedside clutter. Servo-c technical data The screen is bright enough to read under harsh ceiling lights yet dimmable for night shifts.

Nurses can tilt and rotate the display so it faces them while they adjust tubing or turn the patient. The integrated handle and relatively small base make it easier to steer the unit through narrow emergency department corridors without bumping into stretchers.

Transport and workflow considerations

Servo-c can be configured for intra-hospital transport, allowing staff to keep the same ventilator on the patient from the emergency room into the ICU. That reduces time spent reconnecting circuits and re-entering settings during critical minutes.

However, the system is heavier and bulkier than dedicated transport ventilators, so some teams still choose a smaller device for long transfers, for example to radiology or surgery. Respiratory therapist Jonas Eriksson notes that ramp inclines and elevator thresholds can still feel awkward with the full cart.

Limitations versus high-end systems

Compared with the flagship Servo-u, Servo-c deliberately omits some advanced lung-protective tools and decision-support options, focusing instead on the most commonly used modes. Hospitals seeking sophisticated recruitment maneuvers or advanced lung monitoring may still opt for higher-tier models.

Servo-c’s standard configuration also centers on invasive ventilation, with non-invasive and nasal CPAP options depending on configuration. Buyers need to match software and hardware options carefully to their case mix, especially if neonatal or long-term non-invasive ventilation is a priority.

Pricing, markets and stock angle

Getinge positions Servo-c as a mid-range ICU ventilator, priced below its premium siblings and focusing on value for hospitals upgrading from basic legacy devices. The system is sold primarily through Getinge’s own sales network in Europe, the Americas, and Asia-Pacific, often as part of broader critical-care deals.

Overall, Servo-c underlines how Getinge continues to lean on its ventilation portfolio in the intensive care segment; Getinge AB shares (ISIN SE0000202624) are listed on Nasdaq Stockholm in Swedish krona.

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.